Ronald E Bruehlman insider trades

Open-market stock purchases and sales by Ronald E Bruehlman, Director at GoodRx Holdings, Inc, from SEC Form 4 filings since Feb 10, 2015.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +31%.

Recent trades

DateStockTradeValue
Jun 16, 2026GDRX GoodRx Holdings, IncBought (not open market)—
May 27, 2026GDRX GoodRx Holdings, IncBought (not open market)—
Feb 8, 2026IQV Iqvia Holdings IncBought (not open market)—
Feb 8, 2026IQV Iqvia Holdings IncSold (not open market)$1.3M
Jan 1, 2026GDRX GoodRx Holdings, IncBought (not open market)—
Nov 8, 2025GDRX GoodRx Holdings, IncBought (not open market)—

Companies traded

  • GDRX GoodRx Holdings, Inc: other filings, last Jun 16, 2026
  • IQV Iqvia Holdings Inc: 3 buys, 1 sale, last Feb 8, 2026
  • IMS IMS Health Holdings, Inc: other filings, last Oct 3, 2016

Get free alerts when Ronald E Bruehlman files a new trade →